RF
NVO icon

Rollins Financial’s Novo Nordisk NVO Stock Holding History

Rollins Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$403K Buy
3,894
+368
+10% +$36.4K 0.08% 74
2023
Q3 		$321K Buy
+3,526
New +$311K 0.08% 79

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Rollins Financial's NVO Position: Q4 2023 in Review

Rollins Financial increased its Novo Nordisk (NVO) stake by 10% in Q4 2023, buying an estimated $36.4K and bringing the position to 3,894 shares worth $403K. The position accounts for 0.08% of the portfolio, ranked #74.

Rollins Financial first reported a position in NVO in Q3 2023 and has held it in 2 quarters since. 1,512 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

  • Rollins Financial held 3,894 shares of Novo Nordisk worth $403K as of Q4 2023.
  • Rollins Financial bought 368 Novo Nordisk shares in Q4 2023, an estimated $36.4K.
  • Novo Nordisk made up 0.08% of Rollins Financial's portfolio in Q4 2023, its #74 holding.
  • Rollins Financial first reported a position in Novo Nordisk in Q3 2023 and has held it in 2 quarters since.
  • 1,512 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on Rollins Financial's 13F filing for Q4 2023, filed 6 Feb 2024.